Research organisation of Wockhardt Limited, the Indian pharmaceutical and biotechnology company headquartered in Mumbai, with its main research centre at Aurangabad in Maharashtra. Carries out discovery and development of new chemical entities, best known for the company's new antibiotics against drug resistant infections including the WCK series with zidebactam and nafithromycin, together with biotechnology work on insulins and other biosimilars, formulation development, analytical and bioequivalence work and regulatory filings for the company's markets.
暂无评论。
留下您的评分和评论